Synlett 2017; 28(15): 1979-1983
DOI: 10.1055/s-0036-1589087
letter
© Georg Thieme Verlag Stuttgart · New York

Efficient Access to Chromeno[4,3-b]quinolines Related to Dependensin

Autoren

  • Jeremy C. Dobrowolski

    a   School of Chemistry, The University of New South Wales Australia, NSW 2052, Australia   eMail: n.kumar@unsw.edu.au
  • Benjamin H. Fraser

    b   The Australian Nuclear Science and Technology Organisation, Kirrawee DC, NSW 2232, Australia
  • Mohan Bhadbhade

    c   Solid State & Elemental Analysis Unit, Mark Wainwright Analytical Centre, Division of Research, UNSW Australia, NSW 2052, Australia
  • David StC. Black

    a   School of Chemistry, The University of New South Wales Australia, NSW 2052, Australia   eMail: n.kumar@unsw.edu.au
  • Naresh Kumar*

    a   School of Chemistry, The University of New South Wales Australia, NSW 2052, Australia   eMail: n.kumar@unsw.edu.au

We thank the Australian Research Council (ARC) Grant DP140102195 for their financial support. JCD thanks University of New South Wales for an Australian Postgraduate Award (APA)
Weitere Informationen

Publikationsverlauf

Received: 09. Mai 2017

Accepted after revision: 28. Juni 2017

Publikationsdatum:
08. August 2017 (online)


Graphical Abstract

Abstract

We report a robust synthesis of novel chromeno[4,3-b]quinoline derivatives structurally similar to the natural product dependensin. The target compounds are accessed through the acid-catalysed condensation of 2-aminoacetophenones or 2-aminochalcones with substituted flavanones, which are in turn obtained from 2-hydroxyacetophenones and benzaldehydes.

 
  • References and Notes

  • 1 Nianhuan Y. Aiming S. Xiaobing W. Seth D. Kit SL. J. Comb. Chem. 2007; 9: 668
  • 2 Nkunya M. Waibel R. Achenbach H. Phytochemistry 1993; 34: 853
  • 3 Devakaram R. Black DStC. Andrews KT. Fisher GM. Davis RA. Kumar N. Bioorg. Med. Chem. 2011; 19: 5199
  • 4 Devakaram R. Black DStC. Choomuenwai V. Davis RA. Kumar N. Bioorg. Med. Chem. 2012; 20: 1527
  • 5 Zeng L.-F. Wang Y. Kazemi R. Xu S. Xu Z.-L. Sanchez TW. Yang L.-M. Debnath B. Odde S. Xie H. J. Med. Chem. 2012; 55: 9492
  • 6 Bedard J. May S. L’Heureux L. Stamminger T. Copsey A. Drach J. Huffman J. Chan L. Jin H. Rando RF. Antimicrob. Agents Chemother. 2000; 44: 929
  • 7 Suresh T. Kumar RN. Mohan P. Asian J. Chem. 2003; 15: 855
  • 8 Mao D. Tang J. Wang W. Liu X. Wu S. Yu J. Wang L. Org. Biomol. Chem. 2015; 13: 2122
  • 9 Ravi M. Chauhan P. Singh S. Kant R. Yadav PP. RSC Adv. 2016; 6: 48774
  • 10 Deodhar M. Black DStC. Kumar N. Tetrahedron 2007; 63: 5227
  • 11 Dobrowolski JC. Katen A. Fraser BH. Bhadbhade M. Black DStC. Kumar N. Tetrahedron Lett. 2016; 57: 5442
  • 12 Representative Procedure for the Preparation of 12q To a mixture of 5,7,8-trimethoxy-2-phenylchroman-4-one (0.16 mmol, 0.050 g) and 2′-amino-5-chlorobenzophenone (0.16 mmol, 0.037 g) was added T3P®in 50% EtOAc (0.32 mmol, 0.102 g), and the reaction mixture was stirred at 80 °C for 24 h. Water (25 mL) was added to dissolve the T3P®and the mixture was extracted with CH2Cl2 (3 × 20 mL). The combined organic extracts were washed with brine, dried over Na2SO4 filtered, and the solvent removed under reduced pressure. The crude product was recrystallised from MeOH to give a white solid. The white solid was filtered and dried to give pure 12q (51%); mp 222–223 °C. 1H NMR (600 MHz, DMSO-d 6): δ = 8.09 (d, J = 9.0 Hz, 1 H), 7.80 (dd, J = 9.0, 2.4 Hz, 1 H), 7.65–7.61 (m, 1 H), 7.51 (ddt, J = 8.7, 7.5, 1.2 Hz, 2 H), 7.36 (tt, J = 7.6, 0.9 Hz, 1 H), 7.24–7.18 (m, 4 H), 7.10–7.00 (m, 3 H), 6.43 (d, J = 3.4, Hz, 1 H), 6.19–6.15 (m, 1 H), 3.91 (s, 3 H), 3.83 (s, 3 H), 3.53 (s, 3 H).13C NMR (151 MHz, DMSO): δ = 155.2, 149.2, 149.0, 146.0, 143.2, 137.6, 133.6, 131.9, 131.3, 130.8, 130.5, 130.3, 129.8, 128.9, 128.6, 128.4, 128.1, 127.4, 126.3, 124.5, 124.3, 124.0, 107.2, 93.1, 75.5, 60.3, 56.5, 55.5. IR (ATR): νmax = 3035, 2929, 2833, 2340, 2102, 1752, 1571 cm–1. HRMS (ESI+, 47 V): m/z calcd for C31H25ClNO4 [M + H]: 510.1467; found: 510.1468.
  • 13 Representative Procedure for the Preparation of 13l To a mixture of 5,7,8-trimethoxyflavanone (0.16 mmol, 0.050 g) and 2′-amino-4,5,6-trimethoxychalcone (0.16 mmol, 0.050 g) was added T3P®in 50% EtOAc (0.32 mmol, 0.102 g), and the reaction mixture was stirred at 80 °C for 24 h. Water (25 mL) was added to dissolve the T3P®and the mixture was extracted with CH2Cl2 (3 × 20 mL). The combined organic extracts were washed with brine, dried over Na2SO4 filtered, and the solvent removed under reduced pressure. The crude product was recrystallised from MeOH to give a yellow crystalline solid. The yellow solid was filtered and dried to give pure 13l (23%); mp 115–116 °C. 1H NMR (600 MHz, DMSO-d 6): δ = 7.72 (dd, J = 16.7, 3.2 Hz, 1 H), 7.36–7.33 (m, 2 H), 7.29–7.27 (m, 7 H), 7.18 (dd, J = 5.1, 2.6 Hz, 2 H), 6.70 (d, J = 6.0 Hz, 1 H), 6.40 (d, J = 4.0 Hz, 1 H), 6.11 (d, J = 16.6 Hz, 1 H), 4.01 (s, 3 H), 3.88 (d, J = 14.3 Hz, 6 H), 3.82 (s, 3 H), 3.67 (s, 3 H), 3.49 (s, 3 H).13C NMR (151 MHz, DMSO): δ = 155.1, 154.8, 154.6, 148.6, 141.9, 131.9, 131.2, 128.4, 127.9, 127.8, 125.8, 125.6, 125.6, 105.0, 93.0, 75.7, 60.5, 60.4, 60.1, 56.5, 55.6, 55.3. IR (ATR): νmax = 3749, 2928, 2298, 1913, 1559 cm–1. HRMS (ESI+, 47 V): m/z calcd for C36H34NO7 [M + H]: 592.2330; found: 592.2333.
  • 14 X-ray Crystallography A suitable single-crystal of 13l (CCDC 1548511), obtained from methanol, was selected under a polarizing microscope (Leica M165Z), mounted on a MicroMount (MiTeGen, USA) consisting of a thin polymer tip with a wicking aperture. Crystallographic data excluding structure factors have been deposited with the Cambridge Crystallographic Data Centre as supplementary publication; number CCDC 1548511. A copy of the data can be obtained free of charge from CCDC, 12 Union Road, Cambridge, CB2 1EZ, UK or e-mail: deposit@ccdc.cam.ac.uk.